Emmaus Life Sciences (EMMA) Short Interest Ratio & Short Volume $0.01 0.00 (-7.80%) As of 05/22/2025 01:35 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Emmaus Life Sciences Short Interest DataEmmaus Life Sciences (EMMA) has a short interest of 1,400 shares. This marks a -75.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 42,012 shares to cover all short positions.Current Short Interest1,400 sharesPrevious Short Interest5,600 sharesChange Vs. Previous Month-75.00%Dollar Volume Sold Short$23.10Short Interest Ratio0.4 Days to CoverLast Record DateApril 30, 2025Outstanding Shares63,866,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume14,000 sharesAverage Trading Volume42,012 sharesToday's Volume Vs. Average33% Short Selling Emmaus Life Sciences? Sign up to receive the latest short interest report for Emmaus Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEMMA Short Interest Over TimeEMMA Days to Cover Over TimeEMMA Percentage of Float Shorted Over Time Emmaus Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20251,400 shares $23.10 -75.0%N/A0.4 $0.02 4/15/20255,600 shares $89.60 +16.7%0.0%0.7 $0.02 3/31/20254,800 shares $82.08 -25.0%0.0%0.2 $0.02 3/15/20256,400 shares $175.36 +30.6%0.0%0.1 $0.03 2/28/20254,900 shares $85.75 -51.5%0.0%0 $0.02 2/15/202510,100 shares $451.47 -53.5%0.0%0.1 $0.04 1/31/202521,700 shares $353.71 +47.6%N/A1.1 $0.02 1/15/202514,700 shares $205.80 +2,000.0%N/A0.6 $0.01 12/31/2024700 shares $5.95 No ChangeN/A0 $0.01 12/15/2024700 shares $4.69 -22.2%N/A0 $0.01 Get the Latest News and Ratings for EMMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024900 shares $26.91 -10.0%N/A0 $0.03 11/15/20241,000 shares $36.50 +42.9%N/A0 $0.04 10/31/2024700 shares $24.50 No ChangeN/A0 $0.04 10/15/2024700 shares $24.50 No ChangeN/A0 $0.04 9/30/2024700 shares $20.86 No ChangeN/A0 $0.03 9/15/2024700 shares $26.25 No ChangeN/A0 $0.04 8/31/2024700 shares $0.21 No ChangeN/A1 $0.00 8/15/2024700 shares $2.10 No ChangeN/A0 $0.00 7/31/2024700 shares $1.75 No ChangeN/A0.1 $0.00 7/15/2024700 shares $49.91 No ChangeN/A0 $0.07 6/30/2024700 shares $70.70 No ChangeN/A0 $0.10 6/15/2024700 shares $64.01 No ChangeN/A0.1 $0.09 5/31/2024700 shares $64.40 No ChangeN/A0.1 $0.09 5/15/2024700 shares $72.10 No ChangeN/A0.3 $0.10 4/30/2024700 shares $70.00 No ChangeN/A0.1 $0.10 4/15/2024700 shares $73.50 -12.5%N/A0.9 $0.11 3/31/2024800 shares $84.00 -89.5%N/A0.1 $0.11 3/15/20247,600 shares $768.36 +33.3%N/A0.4 $0.10 2/29/20245,700 shares $676.02 +714.3%N/A0.1 $0.12 2/15/2024700 shares $67.27 -93.6%N/A0.1 $0.10 1/15/20244,100 shares $369.00 -6.8%N/A0.4 $0.09 12/31/20234,400 shares $440.33 +450.0%N/A0 $0.10 12/15/2023800 shares $88.00 -50.0%N/A0.1 $0.11 11/30/20231,600 shares $208.00 +128.6%N/A0 $0.13 11/15/2023700 shares $77.00 No ChangeN/A0 $0.11 10/31/2023700 shares $84.00 No ChangeN/A0 $0.12 10/15/2023700 shares $105.00 -22.2%N/A0 $0.15 9/30/2023900 shares $112.50 No ChangeN/A0.5 $0.13 9/15/2023900 shares $117.00 +28.6%N/A0.1 $0.13 8/31/2023700 shares $105.88 -41.7%N/A0 $0.15Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 8/15/20231,200 shares $252.00 No ChangeN/A0.4 $0.21 7/31/20231,200 shares $264.00 +71.4%N/A0.2 $0.22 7/15/2023700 shares $168.35 -50.0%N/A0.1 $0.24 6/30/20231,400 shares $322.00 -68.9%N/A0.2 $0.23 6/15/20234,500 shares $1,215.00 -65.1%N/A0.8 $0.27 5/31/202312,900 shares $4,128.00 +1,742.9%N/A0.5 $0.32 5/15/2023700 shares $224.00 -83.7%N/A0 $0.32 4/30/20234,300 shares $1,354.50 -4.4%N/A0.2 $0.32 4/15/20234,500 shares $1,485.00 +50.0%N/A0.1 $0.33 3/31/20233,000 shares $907.50 +328.6%N/A0.3 $0.30 3/15/2023700 shares $245.00 No ChangeN/A0.1 $0.35 2/28/2023700 shares $266.00 -91.9%N/A0.1 $0.38 2/15/20238,600 shares $4,042.00 +244.0%N/A0.2 $0.47 1/31/20232,500 shares $999.50 +257.1%N/A0 $0.40 1/15/2023700 shares $203.00 No ChangeN/A0 $0.29 12/30/2022700 shares $182.21 -87.7%N/A0 $0.26 12/15/20225,700 shares $1,881.00 +714.3%N/A0.2 $0.33 11/30/2022700 shares $271.60 -86.0%N/A0 $0.39 11/15/20225,000 shares $1,500.00 +72.4%N/A0.2 $0.30 10/31/20222,900 shares $1,305.00 +314.3%N/A0 $0.45 10/15/2022700 shares $126.00 No ChangeN/A0 $0.18 9/30/2022700 shares $119.00 -53.3%N/A0 $0.17 9/15/20221,500 shares $450.00 No ChangeN/A0.2 $0.30 8/31/20221,500 shares $540.00 +87.5%N/A0.1 $0.36 8/15/2022800 shares $296.00 +14.3%N/A0 $0.37 7/31/2022700 shares $245.00 No ChangeN/A0 $0.35 7/15/2022700 shares $280.00 No ChangeN/A0.1 $0.40 6/30/2022700 shares $315.00 No ChangeN/A0.1 $0.45 6/15/2022700 shares $252.00 -66.7%N/A0 $0.36 5/31/20222,100 shares $840.00 -83.5%N/A0 $0.40 5/15/202212,700 shares $3,190.24 +693.8%N/A0.2 $0.25 4/30/20221,600 shares $1,280.00 -5.9%N/A0.2 $0.80 4/15/20221,700 shares $1,292.77 +142.9%N/A0 $0.76 3/31/2022700 shares $700.00 -12.5%N/A0 $1.00 3/15/2022800 shares $1,088.00 No ChangeN/A0.1 $1.36 2/28/2022800 shares $1,160.00 -33.3%N/A0 $1.45 2/15/20221,200 shares $1,740.00 +71.4%N/A0 $1.45 1/31/2022700 shares $980.00 -12.5%N/A0 $1.40 1/15/2022800 shares $1,148.00 +14.3%N/A0 $1.44 12/31/2021700 shares $1,169.00 No ChangeN/A0 $1.67 12/15/2021700 shares $1,071.00 -50.0%N/A0 $1.53 11/30/20211,400 shares $3,010.00 -57.6%N/A0 $2.15 11/15/20213,300 shares $4,026.00 +230.0%N/A0.1 $1.22 10/29/20211,000 shares $1,430.00 -23.1%N/A0.1 $1.43 10/15/20211,300 shares $2,106.00 No ChangeN/A0.1 $1.62 9/30/20211,300 shares $2,080.00 +44.4%N/A0.1 $1.60 9/15/2021900 shares $1,296.00 -79.6%N/A0 $1.44 8/31/20214,400 shares $6,820.00 +46.7%N/A0.3 $1.55 8/13/20213,000 shares $4,650.00 -37.5%N/A0.3 $1.55 7/30/20214,800 shares $7,200.00 +433.3%N/A0.4 $1.50The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 7/15/2021900 shares $1,350.00 No ChangeN/A0.1 $1.50 6/30/2021900 shares $1,278.00 -70.0%N/A0.1 $1.42 6/15/20213,000 shares $4,800.00 +150.0%N/A0.3 $1.60 5/28/20211,200 shares $1,944.00 +33.3%N/A0.2 $1.62 5/14/2021900 shares $1,305.00 -74.3%N/A0 $1.45 4/30/20213,500 shares $4,515.00 +288.9%N/A0.1 $1.29 4/15/2021900 shares $1,215.00 +28.6%N/A0.1 $1.35 3/31/2021700 shares $1,197.00 No ChangeN/A0 $1.71 3/15/2021700 shares $1,050.00 -50.0%N/A0 $1.50 2/26/20211,400 shares $1,974.00 -33.3%N/A0 $1.41 2/12/20212,100 shares $3,507.00 -12.5%N/A0 $1.67 1/29/20212,400 shares $2,928.00 -11.1%N/A0.8 $1.22 1/15/2021700 shares $861.00 -68.2%N/A0 $1.23 12/31/2020700 shares $805.00 No ChangeN/A0 $1.15 12/15/2020700 shares $770.00 -68.2%N/A0 $1.10 11/30/20202,200 shares $2,640.00 -31.3%N/A0.1 $1.20 11/15/20203,200 shares $2,720.00 +3.2%N/A0.1 $0.85 10/30/20203,100 shares $2,542.00 -75.2%N/A0.2 $0.82 10/15/202012,500 shares $9,400.00 +468.2%N/A0.3 $0.75 9/30/20202,200 shares $2,134.00 +144.4%N/A0.1 $0.97 9/15/2020900 shares $1,044.00 -40.0%N/A0 $1.16 EMMA Short Interest - Frequently Asked Questions What is Emmaus Life Sciences' current short interest? Short interest is the volume of Emmaus Life Sciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,400 shares of EMMA short. Learn More on Emmaus Life Sciences' current short interest. Is Emmaus Life Sciences' short interest increasing or decreasing? Emmaus Life Sciences saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 1,400 shares, a decrease of 75.0% from the previous total of 5,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Emmaus Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Emmaus Life Sciences: Purple Biotech Ltd (2.49%), Aoxing Pharmaceutical Company, Inc. (0.00%), Revelation Biosciences, Inc. (7.22%), GRI Bio, Inc. (5.50%), iBio, Inc. (11.10%), Spruce Biosciences, Inc. (1.36%), Qualigen Therapeutics, Inc. (6.52%), Vaccinex, Inc. (5.39%), Pasithea Therapeutics Corp. (1.85%), Scinai Immunotherapeutics Ltd. (0.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Emmaus Life Sciences stock? Short selling EMMA is an investing strategy that aims to generate trading profit from Emmaus Life Sciences as its price is falling. EMMA shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emmaus Life Sciences? A short squeeze for Emmaus Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EMMA, which in turn drives the price of the stock up even further. How often is Emmaus Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMMA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Vivesto Short Squeeze Kazia Therapeutics Short Squeeze Virax Biolabs Group Short Squeeze Palisade Bio Short Squeeze Lixte Biotechnology Short Squeeze 60 Degrees Pharmaceuticals Short Squeeze SciSparc Short Squeeze Organovo Short Squeeze RedHill Biopharma Short Squeeze Enveric Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EMMA) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EMMA Stock Free EMMA Stock Alerts